Alyeska Investment Group
RPTX

Alyeska Investment Group’s Repare Therapeutics RPTX Stock Holding History

Alyeska Investment Group’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,330
Closed -$1.73M – 816
2020
Q4 		$1.73M Sell
50,330
-100,400
-67% -$3M 0.02% 386
2020
Q3 		$4.64M Hold
150,730
– – 0.07% 271
2020
Q2 		$4.68M Buy
+150,730
New +$4.84M 0.07% 275

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alyeska Investment Group's RPTX Position: Q1 2021 in Review

Alyeska Investment Group sold out of Repare Therapeutics (RPTX) in Q1 2021, closing a stake of 50,330 shares — an estimated $1.73M sold.

Alyeska Investment Group first reported a position in RPTX in Q2 2020 and held it in 3 quarters. The position peaked at $4.68M in Q2 2020. 65 funds tracked by Wall St. Rank hold RPTX as of Q1 2021.

  • Alyeska Investment Group reported no remaining Repare Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 50,330 Repare Therapeutics shares in Q1 2021, an estimated $1.73M.
  • Alyeska Investment Group first reported a position in Repare Therapeutics in Q2 2020 and held it in 3 quarters.
  • Alyeska Investment Group's Repare Therapeutics position peaked at $4.68M in Q2 2020.
  • 65 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.